En Es
Products
Covid-19
Companies
Pre-Owned
News
Events
About Us       Join now!
Categories

Browse Products by Category

Critical Care

Emergency Medicine

Intensive Care

Respiratory Care

Anesthesiology Systems

Home Care

Rehabilitation

Other

Hospital Infrastructure

IT Equipment

Transportation Systems

Waste Management

Other

Medical Imaging

Computed Tomography

Digital Radiography

Image Management Systems

Interventional Radiology

Magnetic Resonance Imaging

Mammography

PACS/RIS

Positron Emission Tomography

Radiation Safety

Radiography

Single-Photon Emission Computed Tomography

Ultrasound

Other

Patient Care

Bariatric Care

Beds

Examination Equipment

Other

Surgery

Endoscopy

Laparoscopy

Laser Surgery

Operating Room Equipment

Sterilization

Surgical Implants

Surgical Instruments

Waste Management

Other

Expo: Clinical Laboratory

Blood & Blood Gas Analyzers

Cell Counters

Centrifuges

Clinical Chemistry Analyzer

Coagulation Analyzers

General Lab

Hematology Analyzers

Immunoassay Systems

Lab Glassware

Microplate Reader

Microscopes

Pipettes

Rapid Tests

Ready-to-use Kits for Analysis

Urine Analyzer

Point-Of-Care Testing

Browse Products by Category

Close

CHEMBIO DIAGNOSTIC SYSTEMS

CHEMBIO DIAGNOSTIC SYSTEMS

Chembio develops, manufactures and commercializes diagnostic solutions and products for the rapid and early detection of HIV and syphilis at the point of care. It has products on the market in over 40 countries and seeks to develop new products to enable early and improved treatment of malaria, Ebola, febrile illness ...
Products Covid-19NewsSummary
Close

Covid-19 CHEMBIO DIAGNOSTIC SYSTEMS

Clinical Laboratory

Digital Reader
DPP Micro Reader

The DPP Micro Reader is a handheld device that enables testing for SARS-CoV-2 and other DPP tests. The maintenance free reader streamlines the point-of-care testing experience with precise and accurate results, minimizing human errors due to visual interpretation.
More details

Digital Reader
DPP Micro Reader II

The DPP Micro Reader II is a handheld device that enables testing for SARS-CoV-2 and streamlines the point-of-care testing experience with precise and accurate results. The maintenance free reader delivers automated results in 15-20 seconds and minimizes human errors due to visual interpretation.
More details

COVID-19 IgM/IgG Test
DPP COVID-19 IgM/IgG System

The DPP COVID-19 IgM/IgG System is an ANVISA Approved rapid test for the detection and differentiation of IgM and IgG antibodies to SARS-CoV-2 in capillary “fingerstick” whole blood, venous whole blood, serum and plasma samples. A simple to use, handheld, portable DPP Micro Reader provides simultaneous and separate detection of IgM and IgG antibodies to SARS-CoV-2 in 15 minutes using a small sample size of only 10 μL.
More details

COVID-19/Flu Rapid Test
Status COVID-19/Flu

The Status COVID-19/Flu is the only FDA EUA visual read rapid test for the simultaneous detection and differential diagnosis of SARS-CoV-2, Influenza Type A & Influenza Type B Antigen in nasopharyngeal swab specimens.
More details

SARS-CoV-2 Antigen Rapid Test
DPP SARS-CoV-2 Antigen

The DPP SARS-CoV-2 Antigen is a CE Marked rapid test for the detection of nucleocapsid protein antigen to SARS-CoV-2 in nasal swab specimens. The results can either be read visually, with our DPP Micro Reader or our DPP Micro Reader II.
More details

Point-Of-Care Testing

Digital Reader
DPP Micro Reader

The DPP Micro Reader is a handheld device that enables testing for SARS-CoV-2 and other DPP tests. The maintenance free reader streamlines the point-of-care testing experience with precise and accurate results, minimizing human errors due to visual interpretation.
More details

Digital Reader
DPP Micro Reader II

The DPP Micro Reader II is a handheld device that enables testing for SARS-CoV-2 and streamlines the point-of-care testing experience with precise and accurate results. The maintenance free reader delivers automated results in 15-20 seconds and minimizes human errors due to visual interpretation.
More details

COVID-19 IgM/IgG Test
DPP COVID-19 IgM/IgG System

The DPP COVID-19 IgM/IgG System is an ANVISA Approved rapid test for the detection and differentiation of IgM and IgG antibodies to SARS-CoV-2 in capillary “fingerstick” whole blood, venous whole blood, serum and plasma samples. A simple to use, handheld, portable DPP Micro Reader provides simultaneous and separate detection of IgM and IgG antibodies to SARS-CoV-2 in 15 minutes using a small sample size of only 10 μL.
More details

COVID-19/Flu Rapid Test
Status COVID-19/Flu

The Status COVID-19/Flu is the only FDA EUA visual read rapid test for the simultaneous detection and differential diagnosis of SARS-CoV-2, Influenza Type A & Influenza Type B Antigen in nasopharyngeal swab specimens.
More details

SARS-CoV-2 Antigen Rapid Test
DPP SARS-CoV-2 Antigen

The DPP SARS-CoV-2 Antigen is a CE Marked rapid test for the detection of nucleocapsid protein antigen to SARS-CoV-2 in nasal swab specimens. The results can either be read visually, with our DPP Micro Reader or our DPP Micro Reader II.
More details
Close

News of CHEMBIO DIAGNOSTIC SYSTEMS

Chembio and Biosynex to Merge, Forging US-French Point-of-Care Testing Powerhouse

02 Feb 2023
Chembio and Biosynex to Merge, Forging US-French Point-of-Care Testing Powerhouse
Biosynex SA, a French company specializing in the design and distribution of rapid tests, and Chembio Diagnostics, Inc., a leading point-of-care diagnostics company in the U.S. that is focused on infectious diseases, have entered into a definitive merger agreement under which Biosynex, through a subsidiary, will acquire Chembio in an all-cash transaction valued at USD 17.2 million.
Read More

Chembio Diagnostics Announces Two New Senior-Level Appointments

25 Oct 2016
Chembio Diagnostics Announces Two New Senior-Level Appointments
Chembio Diagnostics, Inc., which develops, manufactures, licenses and markets rapid point-of-care (POC) diagnostic tests for infectious diseases, has made two new senior-level appointments.
Read More
Close

About CHEMBIO DIAGNOSTIC SYSTEMS

Chembio develops, manufactures and commercializes diagnostic solutions and products for the rapid and early detection of HIV and syphilis at the point of care. It has products on the market in over 40 countries and seeks to develop new products to enable early and improved treatment of malaria, Ebola, febrile illness, dengue fever and influenza.

Recently updated

Influenza Type A & B Antigen Test
Status Flu A & B

Status Flu A & B is a CLIA Waived in vitro rapid qualitative test that detects Influenza Types A and B antigens directly from nasal or nasopharyngeal swab specimens. It features an innovative flip design with onboard sample extraction and provides fast results in 10-15 minutes with its visual read eliminating capital equipment analyzer costs.
More details

Ebola Virus Test
DPP Ebola Antigen System

The DPP Ebola Antigen System is a 15 minute rapid test for the detection of Ebola virus specific antigen in fingerstick whole blood, EDTA venous whole blood and EDTA plasma. It provides objective results using a simple, handheld digital reader (DPP Micro Reader) in as little as 15 minutes.
More details

Zika, Chikungunya and Dengue Rapid Test
DPP ZCD IgM/IgG System

The DPP ZCD IgM/IgG System is the world’s first multiplex POC rapid test for detection of Zika, Chikungunya and Dengue and also differentiates between active and past infections through the detection of IgM and IgG antibodies. The CE-marked multiplex test for differential diagnosis of the three mosquito-borne diseases provides objective results using simple, handheld digital reader (DPP Micro Reader).
More details

Clinical Laboratory

Influenza Type A & B Antigen Test
Status Flu A & B

Status Flu A & B is a CLIA Waived in vitro rapid qualitative test that detects Influenza Types A and B antigens directly from nasal or nasopharyngeal swab specimens. It features an innovative flip design with onboard sample extraction and provides fast results in 10-15 minutes with its visual read eliminating capital equipment analyzer costs.
More details

Ebola Virus Test
DPP Ebola Antigen System

The DPP Ebola Antigen System is a 15 minute rapid test for the detection of Ebola virus specific antigen in fingerstick whole blood, EDTA venous whole blood and EDTA plasma. It provides objective results using a simple, handheld digital reader (DPP Micro Reader) in as little as 15 minutes.
More details

Zika, Chikungunya and Dengue Rapid Test
DPP ZCD IgM/IgG System

The DPP ZCD IgM/IgG System is the world’s first multiplex POC rapid test for detection of Zika, Chikungunya and Dengue and also differentiates between active and past infections through the detection of IgM and IgG antibodies. The CE-marked multiplex test for differential diagnosis of the three mosquito-borne diseases provides objective results using simple, handheld digital reader (DPP Micro Reader).
More details

SARS-CoV-2 Antigen Rapid Test
DPP SARS-CoV-2 Antigen

The DPP SARS-CoV-2 Antigen is a CE Marked rapid test for the detection of nucleocapsid protein antigen to SARS-CoV-2 in nasal swab specimens. The results can either be read visually, with our DPP Micro Reader or our DPP Micro Reader II.
More details

COVID-19/Flu Rapid Test
Status COVID-19/Flu

The Status COVID-19/Flu is the only FDA EUA visual read rapid test for the simultaneous detection and differential diagnosis of SARS-CoV-2, Influenza Type A & Influenza Type B Antigen in nasopharyngeal swab specimens.
More details

COVID-19 IgM/IgG Test
DPP COVID-19 IgM/IgG System

The DPP COVID-19 IgM/IgG System is an ANVISA Approved rapid test for the detection and differentiation of IgM and IgG antibodies to SARS-CoV-2 in capillary “fingerstick” whole blood, venous whole blood, serum and plasma samples. A simple to use, handheld, portable DPP Micro Reader provides simultaneous and separate detection of IgM and IgG antibodies to SARS-CoV-2 in 15 minutes using a small sample size of only 10 μL.
More details

Digital Reader
DPP Micro Reader II

The DPP Micro Reader II is a handheld device that enables testing for SARS-CoV-2 and streamlines the point-of-care testing experience with precise and accurate results. The maintenance free reader delivers automated results in 15-20 seconds and minimizes human errors due to visual interpretation.
More details

Digital Reader
DPP Micro Reader

The DPP Micro Reader is a handheld device that enables testing for SARS-CoV-2 and other DPP tests. The maintenance free reader streamlines the point-of-care testing experience with precise and accurate results, minimizing human errors due to visual interpretation.
More details

HIV Test
HIV 1/2 STAT-PAK DIPSTICK Assay

The HIV 1/2 STAT-PAK DIPSTICK tests are easy-to-perform, single-use diagnostic tests for the rapid, visual detection of antibodies to HIV 1 and HIV 2. It requires a minimal sample size of 5 µL and is ideally suited for field and point-of-care testing.
More details

HIV Test
STAT-VIEW HIV 1/2 Assay

The STAT-VIEW HIV 1/2 Assay is a unique, easy-to-use, self-contained, single-use collection and testing device for the rapid, visual detection of antibodies to HIV 1 and HIV. It requires a minimal sample size of 2.5 µL and is ideally suited for field and point-of-care testing.
More details

T. cruzi. Test
Chagas STAT-PAK Assay

The Chagas STAT-PAK Assay is easy to perform, requires no cold chain storage, uses a minimal sample size, and provides visual detection of antibodies to T. cruzi. It requires a minimal sample size of 10 µL whole blood, 5 µL serum or plasma and is ideally suited for field and point-of-care testing.
More details

HIV 1/2 Test
SURE CHECK HIV 1/2 Assay

The SURE CHECK HIV 1/2 Assay is a unique, easy-to-use, self-contained, single-use collection and testing device for the rapid, visual detection of antibodies to HIV 1 and HIV 2. It provides results in 15 minutes from serum, plasma, fingerstick and venipuncture whole blood.
More details

HIV 1/2 Test
DPP HIV 1/2 Assay

The DPP HIV 1/2 Assay is a CLIA-waived test for the rapid detection of HIV 1 and HIV 2 antibodies in oral fluid and all blood matrices. It is intended for use as a POC test to aid in the diagnosis of infection with HIV 1 and HIV 2 and is suitable for use in multi-test algorithms that have been established in many countries or as a standalone initial test.
More details

Syphilis Test
DPP Syphilis Screen & Confirm Assay

The DPP Syphilis Screen & Confirm Assay is a rapid POC test that simultaneously and separately detects treponemal and nontreponemal antibodies. It provides results in as little as 15 minutes, enabling physicians to make treatment decisions, while reducing overtreatment rate and cost burden by eliminating repeated visits to healthcare professionals.
More details

DPP Zika IgM/IgG System
DPP Zika IgM/IgG System

The DPP Zika IgM/IgG System comprises single-use point-of-care (POC) assays for use with a reader for the discrete, semi-quantitative detection of Immunoglobulin M (IgM) and Immunoglobulin G (IgG) antibodies to Zika Virus. It uses ready-to-use reagents (no special preparation of reagents required) and a simple procedure to deliver rapid results in 15 minutes.
More details

Rapid Test System
DPP Zika IgM System

The DPP Zika IgM System is a 15 minute rapid test for detecting Zika virus IgM antibodies in fingerstick whole blood, EDTA venous whole blood, EDTA plasma and serum. The easy to use handheld digital reader provides objective results and detects Zika virus IgM antibodies from 8 days up to 12 weeks.
More details

HIV-Syphilis Assay Test
DPP HIV-Syphilis Assay

The DPP HIV-Syphilis Assay is a single-use, immunochromatographic, rapid test for the detection of antibodies to Human Immunodeficiency Virus Types 1 and 2 (HIV 1/2) and Treponema pallidum (the causative agent of syphilis) in fingerstick whole blood, venous whole blood, serum, and plasma. It is intended for use as a point-of-care test to aid in the diagnosis of infection with HIV and/or Syphilis, and is suitable for use in multi-test algorithms designed for the statistical validation of rapid HIV test results.
More details

Point-Of-Care Testing

Ebola Virus Test
DPP Ebola Antigen System

The DPP Ebola Antigen System is a 15 minute rapid test for the detection of Ebola virus specific antigen in fingerstick whole blood, EDTA venous whole blood and EDTA plasma. It provides objective results using a simple, handheld digital reader (DPP Micro Reader) in as little as 15 minutes.
More details

Zika, Chikungunya and Dengue Rapid Test
DPP ZCD IgM/IgG System

The DPP ZCD IgM/IgG System is the world’s first multiplex POC rapid test for detection of Zika, Chikungunya and Dengue and also differentiates between active and past infections through the detection of IgM and IgG antibodies. The CE-marked multiplex test for differential diagnosis of the three mosquito-borne diseases provides objective results using simple, handheld digital reader (DPP Micro Reader).
More details

SARS-CoV-2 Antigen Rapid Test
DPP SARS-CoV-2 Antigen

The DPP SARS-CoV-2 Antigen is a CE Marked rapid test for the detection of nucleocapsid protein antigen to SARS-CoV-2 in nasal swab specimens. The results can either be read visually, with our DPP Micro Reader or our DPP Micro Reader II.
More details

COVID-19/Flu Rapid Test
Status COVID-19/Flu

The Status COVID-19/Flu is the only FDA EUA visual read rapid test for the simultaneous detection and differential diagnosis of SARS-CoV-2, Influenza Type A & Influenza Type B Antigen in nasopharyngeal swab specimens.
More details

COVID-19 IgM/IgG Test
DPP COVID-19 IgM/IgG System

The DPP COVID-19 IgM/IgG System is an ANVISA Approved rapid test for the detection and differentiation of IgM and IgG antibodies to SARS-CoV-2 in capillary “fingerstick” whole blood, venous whole blood, serum and plasma samples. A simple to use, handheld, portable DPP Micro Reader provides simultaneous and separate detection of IgM and IgG antibodies to SARS-CoV-2 in 15 minutes using a small sample size of only 10 μL.
More details

Digital Reader
DPP Micro Reader II

The DPP Micro Reader II is a handheld device that enables testing for SARS-CoV-2 and streamlines the point-of-care testing experience with precise and accurate results. The maintenance free reader delivers automated results in 15-20 seconds and minimizes human errors due to visual interpretation.
More details

Digital Reader
DPP Micro Reader

The DPP Micro Reader is a handheld device that enables testing for SARS-CoV-2 and other DPP tests. The maintenance free reader streamlines the point-of-care testing experience with precise and accurate results, minimizing human errors due to visual interpretation.
More details

HIV Test
HIV 1/2 STAT-PAK DIPSTICK Assay

The HIV 1/2 STAT-PAK DIPSTICK tests are easy-to-perform, single-use diagnostic tests for the rapid, visual detection of antibodies to HIV 1 and HIV 2. It requires a minimal sample size of 5 µL and is ideally suited for field and point-of-care testing.
More details

HIV Test
STAT-VIEW HIV 1/2 Assay

The STAT-VIEW HIV 1/2 Assay is a unique, easy-to-use, self-contained, single-use collection and testing device for the rapid, visual detection of antibodies to HIV 1 and HIV. It requires a minimal sample size of 2.5 µL and is ideally suited for field and point-of-care testing.
More details

T. cruzi. Test
Chagas STAT-PAK Assay

The Chagas STAT-PAK Assay is easy to perform, requires no cold chain storage, uses a minimal sample size, and provides visual detection of antibodies to T. cruzi. It requires a minimal sample size of 10 µL whole blood, 5 µL serum or plasma and is ideally suited for field and point-of-care testing.
More details

HIV 1/2 Test
SURE CHECK HIV 1/2 Assay

The SURE CHECK HIV 1/2 Assay is a unique, easy-to-use, self-contained, single-use collection and testing device for the rapid, visual detection of antibodies to HIV 1 and HIV 2. It provides results in 15 minutes from serum, plasma, fingerstick and venipuncture whole blood.
More details

HIV 1/2 Test
DPP HIV 1/2 Assay

The DPP HIV 1/2 Assay is a CLIA-waived test for the rapid detection of HIV 1 and HIV 2 antibodies in oral fluid and all blood matrices. It is intended for use as a POC test to aid in the diagnosis of infection with HIV 1 and HIV 2 and is suitable for use in multi-test algorithms that have been established in many countries or as a standalone initial test.
More details

Syphilis Test
DPP Syphilis Screen & Confirm Assay

The DPP Syphilis Screen & Confirm Assay is a rapid POC test that simultaneously and separately detects treponemal and nontreponemal antibodies. It provides results in as little as 15 minutes, enabling physicians to make treatment decisions, while reducing overtreatment rate and cost burden by eliminating repeated visits to healthcare professionals.
More details

HIV-Syphilis Assay Test
DPP HIV-Syphilis Assay

The DPP HIV-Syphilis Assay is a single-use, immunochromatographic, rapid test for the detection of antibodies to Human Immunodeficiency Virus Types 1 and 2 (HIV 1/2) and Treponema pallidum (the causative agent of syphilis) in fingerstick whole blood, venous whole blood, serum, and plasma. It is intended for use as a point-of-care test to aid in the diagnosis of infection with HIV and/or Syphilis, and is suitable for use in multi-test algorithms designed for the statistical validation of rapid HIV test results.
More details
Copyright © 2000-2024 TradeMed.com. All rights reserved. | Terms And Conditions